fashion -WSS

fashion

author：explore 2025-08-19 18:06:42 - browse：74

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Travel bans should be based on evidence, not politics or fear

hotspot

WSS

FTX founder Sam Bankman

Discs beat pads, tampons for heavy menstrual flow, new study shows

Sage's campaign to raise awareness of postpartum depression hits a nerve

What to know about OceanGate, the company behind the missing Titanic submersible

How the political right came to back psychedelics to treat trauma

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Hollywood unions extend contract negotiations for actors

Leqembi, other new Alzheimer’s drugs require better biomarkers

Supreme Court strikes down use of affirmative action

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Medicare details structure of new drug price negotiation program

HCA discloses massive data breach affecting 11 million patients

Affirmative action in medical school literally saved lives

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

focus

‘The Bear’ and hospitality in hospitals

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

‘The Bear’ and hospitality in hospitals

Biden praises World Series champion Astros for impact off the field during White House celebration

Judge rejects Trump's counterclaim against E. Jean Carroll

Oak trusses raised to roof of fire

hotspot

entertainment

hotspot

leisure time